Psychedelics: Old trips, new destinations in psychopharmacology research

[1]  T. Hillhouse,et al.  How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework , 2022, Psychopharmacology.

[2]  A. Pehrson,et al.  The role of serotonin neurotransmission in rapid antidepressant actions , 2022, Psychopharmacology.

[3]  M. Mehta,et al.  Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD , 2022, Psychopharmacology.

[4]  L. F. Berro,et al.  Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice , 2022, Psychopharmacology.

[5]  Kelan Thomas,et al.  Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review , 2022, Psychopharmacology.

[6]  P. Popik,et al.  Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats , 2022, Psychopharmacology.

[7]  L. O. Maia,et al.  Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil , 2022, Psychopharmacology.

[8]  S. Borgwardt,et al.  Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants , 2022, Psychopharmacology.

[9]  J. Ramaekers,et al.  Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study , 2022, Psychopharmacology.

[10]  S. Barker.  Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT , 2022, Psychopharmacology.

[11]  D. Hellerstein,et al.  Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research , 2022, Psychopharmacology.

[12]  R. Carhart-Harris,et al.  Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience , 2022, Journal of psychopharmacology.

[13]  Jacob S. Aday,et al.  Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials , 2021, Psychopharmacology.

[14]  S. Ribeiro,et al.  Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow , 2021, Psychopharmacology.

[15]  H. de Wit,et al.  Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults , 2021, Psychopharmacology.

[16]  M. Liechti,et al.  Safety pharmacology of acute LSD administration in healthy subjects , 2021, Psychopharmacology.

[17]  Jaime E. C. Hallak,et al.  The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020) , 2021, Psychopharmacology.

[18]  Hiba Z. Vohra,et al.  Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice , 2021, Psychopharmacology.

[19]  Kelan Thomas,et al.  Serotonin toxicity of serotonergic psychedelics , 2021, Psychopharmacology.

[20]  M. van Elk,et al.  Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study , 2021, Psychopharmacology.

[21]  Therapeutic Effect , 2020, Definitions.